Dr. Poovamma CU - Senior Consultant & Director - Breast Oncology, Cytecare Hospitals in a recent interaction with India Pharma Outlook shares her views on how innovations such as AI-driven imaging
By:Dr. Poovamma CU - Senior Consultant & Director - Breast Oncology, Cytecare...
BY:Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India, Head of CDSCO
While speaking at the 19th International Conference of Drug Regulatory Authorities, the Drug Controller General of India, Dr. Rajeev Singh...
BY:Dr. Paromita Kanjilal, Consultant - Emergency Medicine, Manipal Hospitals
Dr. Paromita Kanjilal Chakraborty is a Consultant in Emergency Medicine with over 8 years of experience. Holding an MBBS, DNB in Family Medicine,...
BY:Navdeep Singh Kathuria, Senior General Manager - Packing, Aurobindo Pharma
Navdeep Singh Kathuria is a seasoned business leader with over 24 years of extensive experience in solid oral formulations. He currently serves
By:Janifha Evangeline, Assistant Editor, India Pharma Outlook
Owing to the direct impact of its products on public health & safety, the pharma sector operates within a highly regulated environment
BY:Janifha Evangeline, Assistant Editor, India Pharma Outlook
A few months ago, lawmakers in Europe signed off on an update to the urban waste water...
BY:Janifha Evangeline, Assistant Editor, India Pharma Outlook
Isomorphic Labs, on the 7th of January this year announced that it has entered into...
BY:Janifha Evangeline, Assistant Editor, India Pharma Outlook
Kindeva Drug Delivery's Woodbury, Minnesota facility that was launched earlier in 2024 was...
Computer aided drug design (CADD) has played a pivotal role in...
A milestone has been achieved by Fortis Hospital, Bengaluru...
India has successfully performed the first human clinical...
.jpg "Usage of Conversational AI in the Health Insurance Sector")
At the Conversational AI and Customer Experience summit last...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
.JPG "HuidaGene's First CRISPR RNA-Editing Therapy for nAMD Cleared by US FDA")
.jpg "Why Adapting Flexibility in IP Rights will Drive Generics Market")
.jpg "Meeting the Challenges of High-Potency API (HPAPI) Production")
